Meyka AI API is live for developers.Start building.
Advertisement
bioAffinity Technologies, Inc.

bioAffinity Technologies, Inc. (BIAF) Stock Overview

Explore bioAffinity Technologies, Inc.’s financial performance, market position, analyst ratings, and future outlook.

BIAF●NASDAQ
HealthcareMedical - Diagnostics & Research
$1.52
$0.01(0.66%)
U.S. Market opens in 15h 1m
Advertisement

bioAffinity Technologies, Inc. (BIAF)

Meyka AI Score

Z

Key Financials

Market Cap6.9M
P/E Ratio-0.44
EPS (TTM)$-4.67
ROE-3.59%
Fundamental Analysis

AI Price Forecasts

1 Month$1.51
3 Months$1.92
1 Year Target$0.84

BIAF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of bioAffinity Technologies, Inc. (BIAF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 36.59, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.84.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.44 and a market capitalization of 6.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.66%
5-Day Change
-18.28%
1-Month Change
-25.12%
3-Month Change
27.73%
6-Month Change
-10.06%
Year-to-Date (YTD) Change
28.81%
1-Year Change
-82.98%
3-Year Change
-97.40%
5-Year Change
-99.39%
All-Time (Max) Change
-99.39%

Contact Information

https://www.bioaffinitytech.com
210 698 5334
22211 West Interstate 10, San Antonio, TX, 78257

Company Facts

57 Employees
IPO DateSep 1, 2022
CountryUS
Actively Trading

Frequently Asked Questions